https://hartman-lab.org/media-mentions/report-on-potential-of-antitumor-cancer-vaccine/2024-02-27T16:04:26-05:00https://hartman-lab.org/media-mentions/commentary-on-breast-cancer-vaccine-trial-at-sabcs/2024-02-27T16:02:54-05:00https://hartman-lab.org/media-mentions/komen-award-held-by-drs-hartman-and-vincent-renamed-and-inspired-by-rhonda-howell/2024-02-27T16:03:49-05:00https://hartman-lab.org/media-mentions/top-5-new-cancer-vaccines-commentary/2024-02-27T16:03:43-05:00https://hartman-lab.org/media-mentions/could-cancer-vaccines-change-the-course-of-cancer-treatment/2024-02-27T16:04:11-05:00https://hartman-lab.org/media-mentions/report-on-our-phase-ii-trial-for-a-her2-breast-cancer-vaccine-in-combination-with-immune-checkpoint-inhibition/2024-02-27T16:04:04-05:00https://hartman-lab.org/media-mentions/identification-of-novel-mechanisms-of-antibody-efficacy-could-lead-to-future-treatments/2024-02-27T16:04:19-05:00https://hartman-lab.org/media-mentions/awarding-of-new-komen-grant-to-hartmanvincent-team-for-dukeunc-collaboration/2024-02-27T16:04:49-05:00https://hartman-lab.org/media-mentions/series-a-funding-for-replicate-biosciences-a-duke-spinout-company/2024-02-27T16:05:00-05:00https://hartman-lab.org/media-mentions/report-on-potential-of-antitumor-cancer-vaccine-2/2024-02-27T16:04:43-05:00